Full Breakdown
CDC Vaccine Advisory Committee Meeting Canceled Amid Policy Overhaul
2/20/2026, 12:50:32 AM
Cancellation of the Advisory Committee Meeting
The Centers for Disease Control and Prevention (CDC) has canceled its Advisory Committee on Immunization Practices (ACIP) meeting originally scheduled for February 25-27, 2026. This decision was confirmed by a spokesperson from the Department of Health and Human Services (HHS), who stated that no new dates for the meeting have been announced. The ACIP plays a critical role in shaping vaccination recommendations that influence health insurance coverage, state school vaccination requirements, and medical advice regarding immunizations.
Policy Changes Under Health Secretary Robert F. Kennedy Jr.
The cancellation of the ACIP meeting coincides with significant policy changes initiated by U.S. Health Secretary Robert F. Kennedy Jr. His administration is working to revise national vaccination policies, which includes eliminating broad recommendations for six childhood vaccines, such as those for COVID-19 and hepatitis B. Additionally, Kennedy is advocating for increased federal support for state vaccine exemptions and a reduction in funding for mRNA vaccine research.
The ACIP has faced considerable restructuring since Kennedy dismissed all 17 of its members in June 2025. The committee's last meeting in December resulted in a vote to remove the recommendation for newborns to receive the hepatitis B vaccine. Following this, the CDC made broad changes to the childhood vaccine schedule, including the removal of recommendations for rotavirus, influenza, meningococcal disease, and hepatitis A vaccines, although these changes did not receive a formal vote from the ACIP.
Leadership Transition at the CDC
In conjunction with these policy shifts, the CDC is undergoing a leadership transition. Jay Bhattacharya, the current Director of the National Institutes of Health, is set to become the acting director of the CDC, replacing Jim O'Neill. This change in leadership may further influence the direction of vaccination policies and the functioning of the ACIP.
Criticism and Opposition
The recent developments have drawn criticism from major U.S. medical groups, which have filed a lawsuit to prevent the ACIP from holding meetings under the new policies. These groups argue that the committee is now dominated by individuals aligned with Kennedy's anti-vaccine views, potentially violating the Federal Advisory Committee Act's requirement for balanced representation. Critics express concern that these changes could lead to lower vaccination rates, which may have broader public health implications.
What's Next
As the CDC navigates these changes, the future of the ACIP and its role in vaccination policy remains uncertain. The agency has indicated that further information regarding the rescheduling of the canceled meeting will be shared as it becomes available. The ongoing legal challenges and public health debates surrounding vaccination policies are likely to continue shaping the landscape of immunization in the United States.
